IDEXX LABORATORIES INC /DE
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions (as of 2025).
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- IDXX [1]
- Listing exchanges
- Nasdaq [1]
- SEC industry
- In Vitro & In Vivo Diagnostic Substances [1]
- Business sectors
- health care [2]
- Company / filing name
- IDEXX LABORATORIES INC /DE [1]
- Headquarters location
- Westbrook [2]
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041 [1]
- Founded
- 1983 [2]
- Legal form
- Delaware corporation [2]
- Incorporation jurisdiction
- Delaware, United States [1]
- Official website
- www.idexx.com ↗ [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US45168D1046 [2]
- CIK
- 0000874716 [1]
- SIC code
- 2835 [1]
- Country in background record
- United States; Netherlands [2]
Company positioning and business
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions (as of 2025). [3]
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO. [3]
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. [3]
Background text: Wikipedia contributors, Idexx Laboratories. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
The SEC submissions record gives IDEXX LABORATORIES INC /DE a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: IDXX (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Related entities and concepts
Frequently asked questions
When was IDEXX LABORATORIES INC /DE founded?
Founded: 1983. The linked source provides the background record. [2]
Where is the headquarters of IDEXX LABORATORIES INC /DE?
Headquarters location: Westbrook. The linked source provides the background record. [2]
Which business sectors are recorded for IDEXX LABORATORIES INC /DE?
Business sectors: health care. The linked source provides the background record. [2]
IDEXX LABORATORIES INC /DE relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — IDEXX LABORATORIES INC /DE filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Idexx Laboratories (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.